Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Exelixis Presents Positive Data
Yahoo/Zacks
Saturday, May 22, 2010 - 9:38am
tags:
XL184, Bristol-Myers Squibb, glioblastoma, brain cancer, melanoma, non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, pancreatic, gastric, prostate, ovarian, breast cancer
Biotechs will have to scramble for a piece of $1B grant pie
Fierce Biotech
Friday, May 21, 2010 - 11:33am
tags:
biotech, grants
How J&J Allowed Its Tylenol Factory to Rage "Out of Control"
BNET Pharma
Friday, May 21, 2010 - 11:29am
tags:
recalls, JNJ, Tylenol
Rituxan, Revlimid win in maintenance trials
Fierce Pharma
Friday, May 21, 2010 - 11:26am
tags:
Rituxan, Revlimid, Genentech, clinical trials, lymphoma, Roche, Biogen Idec
What the Company That Let Spiders in Its Drugs Tells Us About Monopolies and Transparency
BNET Pharma
Friday, May 21, 2010 - 11:25am
tags:
Braintree Labs, warnings, FDA
Glaxo Struggles To Recruit Patients For Avandia Trial
Pharmalot
Friday, May 21, 2010 - 11:20am
tags:
Avandia, GSK, clinical trials, diabetes
Statins Raise Cataract, Kidney Risk in Study
Bloomberg
Friday, May 21, 2010 - 11:16am
tags:
statins, cataracts, kidney failure
Abbott falls on acquisition deal; Anadys climbs
Marketwatch
Friday, May 21, 2010 - 11:14am
tags:
Abbott Laboratories, Anadys, M&A, Piramal Healthcare
Ligand Pharma buys rights to AstraZeneca drug
Yahoo/AP
Friday, May 21, 2010 - 11:10am
tags:
Ligand, AstraZeneca, asthma
Aspen Offers $1.24 Billion for Sigma Pharmaceuticals
Bloomberg
Friday, May 21, 2010 - 11:05am
tags:
Apsen, M&A, Sigma
Amgen’s Crop of Experimental Cancer Drugs Shows Initial Results
Bloomberg
Friday, May 21, 2010 - 10:47am
tags:
Amgen, cancer, pancreatic cancer, ovarian cancer, pipelines, denosumab
Lilly Aims Big in Oncology
Yahoo/Zacks.com
Friday, May 21, 2010 - 10:43am
tags:
Eli Lilly, oncology, ASCO, tasisulam
Abbott buys India drugs unit for $3.7bn
FT.com
Friday, May 21, 2010 - 6:59am
tags:
Abbott Laboratories, India, M&A, Piramal Healthcare
What Investors Think About XenoPort
Motley Fool
Thursday, May 20, 2010 - 6:38pm
tags:
XenoPort
Pediatric drug spending growing fast
Fierce Pharma
Thursday, May 20, 2010 - 6:37pm
tags:
pediatrics, drug sales, prescription data
The Little Company That Couldn't: Why No One Cares About MannKind's Potential Diabetes Blockbuster
BNET Pharma
Thursday, May 20, 2010 - 6:32pm
tags:
MannKind, diabetes, inhaled insulin
Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Bloomberg
Thursday, May 20, 2010 - 6:29pm
tags:
Amgen, cancer, pancreatic cancer, ovarian cancer, conatumumab
‘Beyond Tone Deaf’: A Scathing Look at Novartis’s Defense Strategy
WSJ Online
Thursday, May 20, 2010 - 6:24pm
tags:
Novartis, lawsuits, discrimination
A.P. Pharma gets Nasdaq delist warning over stock price
bizjournals.com
Thursday, May 20, 2010 - 11:21am
tags:
A.P. Pharma, investors
Pfizer Oncology to Present New Clinical Data From Ten Molecules Across Multiple Tumor Types
Yahoo/PR NewsWire
Thursday, May 20, 2010 - 11:20am
tags:
Pfizer, Clovis Oncology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.